Results 21 to 30 of about 410,880 (314)

Management of advanced breast cancer

open access: yesAnnals of Oncology, 2007
Metastatic breast cancer (MBC) is usually considered an incurable situation, for which treatments chosen to control the disease, should take into account the maintenance of a good quality of life. The end points of treatment of patients with MBC are influenced by consideration about efficacy and toxicity of the different therapeutic options.
L, Orlando   +7 more
openaire   +2 more sources

Menopausal hot flushes after breast cancer [PDF]

open access: yes, 2009
The study aimed to improve understanding of the natural history and impact of hot flushes after breast cancer.Data were collected from women participating in an RCT of relaxation to reduce the incidence of flushes from breast cancer follow-up clinics ...
Fenlon, D.R., Corner, J.L., Haviland, J.
core   +1 more source

Important research progress in clinical practice for advanced breast cancer in 2023 [PDF]

open access: yesZhongguo aizheng zazhi
The comprehensive diagnosis and treatment of advanced breast cancer has entered the era of "accurate classification and precise stratification", and is moving towards the road of personalized precision medicine.
Siyuan ZHANG, Zefei JIANG
doaj   +2 more sources

A hard pill to swallow: a qualitative study of women’s experiences of adjuvant endocrine therapy for breast cancer [PDF]

open access: yes, 2014
Objective: To explore women’s experiences of taking adjuvant endocrine therapy as a treatment for breast cancer and how their beliefs about the purpose of the medication, side effects experienced and interactions with health professionals might influence
McCowan, Colin   +16 more
core   +1 more source

Observed and Predicted Risk of Breast Cancer Death in Randomized Trials on Breast Cancer Screening. [PDF]

open access: yesPLoS ONE, 2016
BACKGROUND:The role of breast screening in breast cancer mortality declines is debated. Screening impacts cancer mortality through decreasing the number of advanced cancers with poor diagnosis, while cancer treatment works through decreasing the case ...
Philippe Autier   +4 more
doaj   +1 more source

The impact of obesity and endocrine therapy on the prognosis of premenopausal women with hormone receptor‐positive breast cancer: A single‐institute retrospective study

open access: yesCancer Reports, 2023
Background Higher body mass index (BMI) is associated with worse prognosis in pre‐ and postmenopausal patients with breast cancer (BC). However, there is insufficient evidence regarding the optimal adjuvant endocrine therapy for obese premenopausal women
Yukinori Ozaki   +10 more
doaj   +1 more source

ABC4 Consensus: First Latin American Meeting—Assessment, Comments, and Application of Its Recommendations

open access: yesJCO Global Oncology, 2020
Breast cancer accounts for a high burden among all the neoplasms in Latin America, with more-advanced stages at presentation, which could result in high mortality rates.
Henry L. Gomez   +5 more
doaj   +1 more source

DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. [PDF]

open access: yes, 2014
Single Nucleotide Polymorphisms (SNPs) in genes involved in the DNA Base Excision Repair (BER) pathway could be associated with cancer risk in carriers of mutations in the high-penetrance susceptibility genes BRCA1 and BRCA2, given the relation of ...
Backes, F.J. (Floor)   +999 more
core   +1 more source

Knowledge in Motion: A decade reviewed, a future defined – The ABC Global Alliance 2015–2025 Decade Report and 2025–2035 Global Charter

open access: yesBreast
Breast cancer remains one of the most significant global health challenges, with approximately 2.3 million new cases diagnosed and 666,000 deaths every year. Advanced breast cancer (ABC) – encompassing locally advanced and metastatic disease – represents
Fatima Cardoso   +4 more
doaj   +1 more source

Resisting ethnic inequities in advanced breast cancer: A call to action

open access: yes, 2022
Māori women with advanced breast cancer are less than half as likely as their Pākehā counterparts to reach the five-year survival mark. We argue that this inequity is unacceptable.
Kereama-Royal, Irene   +5 more
core  

Home - About - Disclaimer - Privacy